Ganeden Biotech granted patent for probiotic

CLEVELAND Ganeden Biotech on Wednesday announced that it was granted a patent by the United States Patent and Trademark Office for its invention utilizing a combination of probiotics and lactase to increase lactose digestion in people with lactose intolerance. Lactose intolerance, or the inability to digest lactose, impacts up to 50 million Americans with symptoms like diarrhea, gas and/or bloating after they consume foods containing dairy.

Taking lactase, the enzyme that breaks down lactose and what people with lactose intolerance lack, is the traditional solution for people with lactose intolerance who want to consume dairy.

“Keeping enough lactase pills handy is hard enough, but since lactose intolerance sufferers often don't know that some of the foods they're eating contain dairy, they may not even think about taking their lactase pills,” stated Rachel Garber, a Cleveland pediatrician who treats lactose intolerant children and teens at her practice. “A better solution would be one that could be taken in the morning and protect you throughout the day against any dairy that might be consumed, knowingly or not.”

Ganeden Biotech’s Digestive Advantage Lactose Intolerance product contains the combination of the probiotic strain of Bacillus coagulans and lactase enzyme covered by patent the patent, “The lactase enzyme market is rather stagnant, with the leading brands declining in sales,” stated Marshall Fong, head of marketing at Ganeden. “We believe this is because it's not the ideal solution to lactose intolerance — it's not always easy to take a lactase pill before eating dairy, especially if you don't know that the food you're about to eat contains dairy.”

Login or Register to post a comment.